Outside the pandemic, “investigational” remains payer code for denying reimbursement. In the case of treatment for chronic conditions, even FDA-approved digital-health and connected devices languish on waitlists for formulary inclusion.
There are two sides to Kratom and two distinct views of it in the public’s mind. Kratom users see the drug as a lifesaver. Some of them consume it for pain, others, as a means to wean themselves off opioids